We invest in creating better health outcomes.

Scienture Holdings, Inc. (SCNX)

About

Scienture Holdings, Inc. (NASDAQ: SCNX) holds existing and planned pharmaceutical operating companies. Focused on providing enhanced value to patients, physicians, and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs.

Learn More

Our Companies

Scienture, LLC

Scienture, LLC is a New York-based pharmaceutical company driven by a highly experienced team passionate about developing unique specialty products that bring enhanced value to patients and healthcare systems.

Learn More

Stock Information

We focus on overcoming significant challenges, which can ultimately enhance the quality of life.

Get the latest information about Scienture Holdings:

Stock Information Filings Resources Corporate Governance Events & Presentations

Press Releases

SCIENTURE Announces Executive Leadership Transition

Learn More

Press Releases

SCIENTURE announces FDA Orange Book Patent Listing for ArbliTM, (losartanpotassium) Oral Suspension, 10mg/mL.

Learn More

Press Releases

SCIENTURE announces manufacturing and supply chain readiness for Arbli™, (losartan potassium) Oral Suspension, 10mg/mL for a target product launch in July 2025.

Learn More

Press Releases

Scienture Holdings, Inc. Issues Annual Letter to Shareholders

Learn More

Press Releases

SCIENTURE Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health, a leading Contract Sales Organization

Learn More

Press Releases

Scienture Holdings Announces Draw on ELOC, Temporarily Suspends Further Draws Until Reaching $10/Share or 30 Trading Days

Learn More

See all